AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 92 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $142,610,000 | +103.1% | 4,139,600 | -1.5% | 0.01% | +150.0% |
| Q2 2020 | $70,226,000 | +17.7% | 4,202,544 | +1.6% | 0.00% | -33.3% |
| Q1 2020 | $59,661,000 | -55.9% | 4,137,346 | +2.4% | 0.00% | -40.0% |
| Q4 2019 | $135,248,000 | +72.1% | 4,040,835 | +7.6% | 0.01% | +66.7% |
| Q3 2019 | $78,603,000 | +1.9% | 3,753,700 | +1.3% | 0.00% | 0.0% |
| Q2 2019 | $77,167,000 | -2.5% | 3,706,394 | +4.6% | 0.00% | 0.0% |
| Q1 2019 | $79,170,000 | -9.9% | 3,542,356 | -3.6% | 0.00% | -25.0% |
| Q4 2018 | $87,908,000 | -10.0% | 3,675,074 | +2.7% | 0.00% | 0.0% |
| Q3 2018 | $97,643,000 | +5.4% | 3,579,306 | +3.9% | 0.00% | 0.0% |
| Q2 2018 | $92,613,000 | -12.0% | 3,444,147 | +4.1% | 0.00% | -20.0% |
| Q1 2018 | $105,293,000 | +7.6% | 3,307,998 | +27.9% | 0.01% | +25.0% |
| Q4 2017 | $97,812,000 | +50.4% | 2,586,272 | -1.4% | 0.00% | +33.3% |
| Q3 2017 | $65,025,000 | +27.7% | 2,623,020 | +5.9% | 0.00% | 0.0% |
| Q2 2017 | $50,923,000 | +6.5% | 2,476,836 | +12.6% | 0.00% | +50.0% |
| Q1 2017 | $47,803,000 | +38.6% | 2,199,858 | +30.5% | 0.00% | 0.0% |
| Q4 2016 | $34,479,000 | +51.2% | 1,686,055 | +10.9% | 0.00% | +100.0% |
| Q3 2016 | $22,809,000 | +57.3% | 1,520,568 | +13.5% | 0.00% | 0.0% |
| Q2 2016 | $14,497,000 | -13.1% | 1,339,847 | +8.9% | 0.00% | 0.0% |
| Q1 2016 | $16,685,000 | +29.8% | 1,230,390 | +76.6% | 0.00% | 0.0% |
| Q4 2015 | $12,856,000 | -94.0% | 696,808 | -88.0% | 0.00% | -87.5% |
| Q3 2015 | $214,585,000 | – | 5,787,312 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|